Is Ubiquiti Networks Still Undervalued?
This tech stock has been rallying and shows no signs of slowing down.
Here's Why Merck Paid Triple the Price for Idenix
Merck pays a hefty price for hepatitis C specialist Idenix Pharmaceuticals.
3 Nasdaq Stocks Investors Love to Hate
The Nasdaq may be approaching another multi-decade high, but don't tell that to short-sellers in these three most hated stocks.
Is Agilent Technologies Due for a Rally?
The tech stock has broken its downtrend, and its moving averages are beginning to slope upward.
Jeff Saut: S&P Suggests Now Is Not the Time to Be Underinvested
Stocks still have room to run, even if there is a short-term pullback on deflation worries in Europe.
Apple Fails to Inspire Investors Today, but the Future Is Bright
Investors are selling the news of Apple's software update, but a longer-term view is necessary.
Todd Harrison: What to Watch as We Slink Into Summer
The NDX holds the key to today's stock market action.